GUTS Stock Summary and Trading Ideas (Fractyl Health | NASDAQ:GUTS)

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Fractyl Health trades on the NASDAQ stock market under the symbol GUTS.

As of January 29, 2026, GUTS stock price declined to $0.58 with 61,364,566 million shares trading.

GUTS has a beta of 0.34, meaning it tends to be less sensitive to market movements. GUTS has a correlation of 0.00 to the broad based SPY ETF.

GUTS has a market cap of $89.71 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that GUTS belongs to (by Net Assets): VTI, VXF, IWC.

GUTS has underperformed the market in the last year with a price return of -70.6% while the SPY ETF gained +16.0%. GUTS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -54.3% and -70.9%, respectively, while the SPY returned +1.3% and +0.5%, respectively.

GUTS support price is $1.71 and resistance is $1.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GUTS shares will trade within this expected range on the day.